Evidence map›Paper›PMID 33398189›Full record

ReviewNature methods2021

A practical guide to cancer subclonal reconstruction from DNA sequencing.

Maxime Tarabichi, Adriana Salcedo, Amit G Deshwar, Máire Ni Leathlobhair, Jeff Wintersinger, David C Wedge, Peter Van Loo, Quaid D Morris, Paul C Boutros

Abstract readReview
In one paragraph

Review in Nature methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The influence of socio-demographics and clinical characteristics on coping strategies in cancer patients: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. LINE-1 retrotransposition is a recurrent cause ofbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cell lineage tracing: Methods, applications, and challenges.Quantitative biology (Beijing, China) · 2025
    Review
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maxime Tarabichi *The Francis Crick Institute, London, UK.
Adriana Salcedo *Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Amit G Deshwar *The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, University of Toronto, Toronto, Ontario, Canada.
Máire Ni Leathlobhair *Big Data Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8523-4935
Jeff WintersingerDepartment of Computer Science, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4538-9470
David C WedgeBig Data Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7572-3196
Peter Van LooThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0292-1949
Quaid D MorrisOntario Institute for Cancer Research, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-2760-6999
Paul C BoutrosDepartment of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. PBoutros@mednet.ucla.edu.ORCID http://orcid.org/0000-0003-0553-7520

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
Advancing method benchmarking and data sharing through crowd-sourced competitions in cancer researchU24CA248265 · NCI · SAGE BIONETWORKS · PI BOUTROS, PAUL CHRISTOPHER, VARMA, SUSHEEL · 2020 to 2024
$4.1M
The Evolution of Sarcoma Drug Sensitivity through Time and SpaceR01CA244729 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOUTROS, PAUL CHRISTOPHER, SORAGNI, ALICE · 2020 to 2024
$3.4M
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate CancerU01CA214194 · NCI · EASTERN VIRGINIA MEDICAL SCHOOL · PI BOUTROS, PAUL CHRISTOPHER, KISLINGER, THOMAS · 2016 to 2021
$2.5M
Cancer Research UK FC001202NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016042NCI NIH HHS P50 CA211015NCI NIH HHS R01 CA244729NCI NIH HHS U01 CA214194NCI NIH HHS U24 CA248265Wellcome Trust FC001202
6 · The paper itself

Abstract

Subclonal reconstruction from bulk tumor DNA sequencing has become a pillar of cancer evolution studies, providing insight into the clonality and relative ordering of mutations and mutational processes. We provide an outline of the complex computational approaches used for subclonal reconstruction from single and multiple tumor samples. We identify the underlying assumptions and uncertainties in each step and suggest best practices for analysis and quality assessment. This guide provides a pragmatic resource for the growing user community of subclonal reconstruction methods.

Indexed as

AlgorithmsDNA, NeoplasmHumansNeoplasmsPolymorphism, Single NucleotideSequence Analysis, DNADNA, Neoplasm

Identifiers

PMID33398189
PMCPMC7867630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.